Few & Far Between: How Biotech Gets Built
BookmarkChris O'Brien
Few & Far Between: How Biotech Gets Built is a science podcast hosted by Chris O'Brien. It has 35 episodes, with the latest published March 2026.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
science ·en ·35 episodes
Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School
Video Episode 68: Sinan Gölhan, CEO at GelTech Labs
Video Episode 67: Aoife Brennan, President and CEO of Climb Bio
Episode 66: Mark Abelson, Founder of Ora Clinical
Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience
Video Episode 64 - Professor Justin Stebbing
Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences
Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology
Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics
Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech
Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech
Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences
Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation
Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
Episode 53: Frank David, Founder and Managing Director, Pharmagellan
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
Episode 48: John Celebi, President and CEO, Sensei Bio
Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures
Episode 47 - Marc Lajoie, CEO at Outpace Bio
Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris
Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics
Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics
Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical
Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health
Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal
Episode 39: Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center
Episode 38: Dr. Ole Isacson, Professor of Neurology and Neuroscience, Harvard Medical School
Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche
Episode 36: Zak Kohane, Department of Biomedical Informatics at Harvard Medical School
Episode 35: Charlene Son Rigby, CEO at Global Genes
Loading reviews...
Loading similar podcasts...